(Q40122714)

17 September 2017

1 reference

title

Development of drug resistance and dependence in viruses (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

author name string

B. Loddo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6255494

8 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6255494

8 September 2023

publication date

1 January 1980

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725880900261?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

https://api.elsevier.com/content/article/PII:0163725880900261?httpAccept=text/plain

8 September 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Pharmacology & Therapeutics

8 September 2023

published in

1 reference

17 September 2017

10

1 reference

17 September 2017

3

1 reference

17 September 2017

431-460

1 reference

Amantadine-resistance as a Genetic Marker for Influenza Viruses

17 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The effect of thiosemicarbazones on the growth of rabbit pox virus in tissue culture

8 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A plaque assay for the study of influenza virus inhibitors

8 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Thiosemicarbazone-resistant rabbitpox virus

8 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of enterovirus cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole

8 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone)

8 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

thiosemicarbazones

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Adenovirus multiplication: inhibition by methisazone

8 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

New antiviral chemotherapeutic agent active against smallpox infection

8 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rifampicin and poxvirus replication

8 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The role of cytoplasmic membranes in poliovirus biosynthesis

8 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Characterization of poliovirus-specific structures associated with cytoplasmic membranes.

8 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

guanidine

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

5-IODO-21A/CAMERMAN N, TROTTER J: 5-IODO-2'-DEOXYURIDINE: RELATION OF STRUCTURE TO ITS ANTIVIRAL ACTIVITY

8 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

STUDIES ON THE GUANIDINE CHARACTER OF POLIOVIRUS

8 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Investigation of the Mechanism of Changes of RS Character of Neurovaccine in Passages in the Presence of Bromodeoxyuridine

8 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Studies on the antiviral activity of amantadine hydrochloride.

8 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus

8 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A genetic map of poliovirus temperature-sensitive mutants

8 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The possible role of the equestron as an Achilles' heel for chemotherapy of picornavirus infections

8 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures

8 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

8 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Electron microscopic observations on the entry of influenza virus into susceptible cells

8 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

ISOLATION AND PROPERTIES OF VACCINIA MUTANTS DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY

8 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY

8 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Plaque formation and isolation of pure lines with poliomyelitis viruses

8 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Interference with the maturation of vaccinia virus by isatin beta-thiosemicarbazone

8 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Selective inhibition of uncoating of echovirus 12 by rhodanine A study on early virus-cell interactions

8 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole

8 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Synergistic Effect of 2-(α-Hydroxybenzyl)- benzimidazole and Guanidine on Picornavirus Reproduction

8 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

COXSACKIE A9 VIRUS: MUTATION FROM DRUG DEPENDENCE TO DRUG INDEPENDENCE.

8 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rhodanine: a selective inhibitor of the multiplication of echovirus 12.

8 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES

8 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Soluble RNA polymerase complex from poliovirus-infected HeLa cells

8 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

DECREASED PATHOGENICITY FOR RABBIT SKIN OF IDU-RESISTANT VACCINIA VIRUS.

8 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The characteristic and relationships of virus resistance and dependence to guanidine and other compounds

8 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of herpes simplex virus replication by araT

8 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Selective inhibition of poliovirus growth by d-Penicillamine in vitro

8 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Common codon characteristic of aminoacids capable to antagonize the antipolio action of guanidine and d-penicillamine.

8 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of Rhinovirus by Isatin Thiosemicarbazone Analogues

8 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

Suppression

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

Pharmacology of Viruses

60

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Mutants of Herpes Simplex Virus Types 1 and 2 that are Resistant to Phosphonoacetic Acid Induce Altered DNA Polymerase Activities in Infected Cells

8 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Selective inhibition of vaccinia virus by the antibiotic rifampicin

8 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Plaque inhibition test for detection of specific inhibitors of DNA containing viruses

8 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A working hypothesis--virus resistance development as an indicator of specific antiviral activity

8 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

CHARACTERS OF GUANIDINE RESISTANT MUTANTS OF TYPE 1 POLIOVIRUS.

8 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSES

8 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1

8 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Incorporation of 5-bromodeoxyuridine and 5-iododeoxyuridine into viral DNA and its effect on the infective process

8 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride

8 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Reversal of Anti-viral Effects of Rifampicin

8 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

An isatin beta-thiosemicarbazone (IBT)-dependent mutant of vaccinia virus: the nature of the IBT-dependent step

8 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Synthesis of Vaccinia Virus Polypeptides in the Presence of Isatin-β-Thiosemicarbazone

8 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Characterization and mixed infections of three strains of vaccinia virus: wild type, IBT-resistant and IBT-dependent mutants

8 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Isolation and Characterization of an IBT-Dependent Mutant of Vaccinia Virus

8 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The effect of isatin beta thiosemicarbazone (IBT)-related compounds on IBT-resistant and on IBT-dependent mutants of vaccinia virus

8 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

In vivo studies with antiviral agents

8 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS.

8 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis

8 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cells

8 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

8 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Phosphonoacetic Acid-Resistant Herpes Simplex Virus Infection in Hairless Mice

8 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Induction with hydroxylamine of guanidine resistance in poliovirus

8 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Poliovirus coat protein as the site of guanidine action

8 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

No effect of guanidine on an improved in-vitro system for viral RNA polymerase.

8 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Specific inhibition of virus multiplication by bichlorinated pyrimidines

8 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Specific inhibition of poliovirus induced blockade of cell protein synthesis by a thiopyrimidine derivative

8 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral activity of gliotoxin.

8 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain

8 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inactivation and inhibition of Rous sarcoma virus by copper-binding ligands: thiosemicarbazones, 8-hydroxyquinolines, and isonicotinic acid hydrazide

8 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inactivation of murine RNA tumor viruses by isatin beta-thiosemicarbazone, its derivatives and analogs

8 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

ANTI-VIRAL ACTIVITY OF TWO GUANIDINE DERIVATIVES IN VITRO

8 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

In vitro Inhibition of Infectivity of Polio Viruses by Guanidine

8 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

In vitro guanidino-resistance and guanidino-dependence of poliovirus

8 September 2023

119

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus

8 September 2023

120

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

REGRESSION OF GUANIDINE-DEPENDENCE IN CLONED GUANIDINE-DEPENDENT POLIO VIRUSES.

8 September 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Protection against poliovirus paralysis by pretreatment with a guanidine-dependent poliovirus strain

8 September 2023

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

DEVELOPMENT OF VACCINIA VIRUS RESISTANT TO 5-IODO-2DEOXYURIDINE

8 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

POLIOVIRUS: GUANIDINE DEPENDENCE AND LOSS OF NEUROVIRULENCE FOR MONKEYS.

8 September 2023

124

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

In vitro polio virus inhibition by two guanidino-pyrimidines

8 September 2023

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Relationship between Guanidine-dependence and Neurovirulence of Poliovirus

8 September 2023

126

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antagonism of the guanidine interference with poliovirus replication by simple methylated and ethylated compounds

8 September 2023

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Structure activity relationships of compounds able to suppress the antipolio action of guanidine

8 September 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Viral synthesis after simultaneous infection with guanidine-sensitive and guanidine-dependent polioviruses

8 September 2023

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Penicillamine Therapy for Rheumatoid Lung Disease: Effects on Protein Sulphydryl Groups

8 September 2023

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

DNA polymerase and deoxyribonucleotide kinase activities in cells infected with vaccinia virus

8 September 2023

138

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Biochemical studies on the antiviral activities of the isatin-beta-thiosemicarbazones

8 September 2023

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Immunological evidence for the appearance of a new DNA-polymerase in cells infected with vaccinia virus

8 September 2023

140

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Impairment of herpesvirus growth in chick embryo fibroblast cultures by?-amanitin

8 September 2023

141

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of DNA polymerase from herpes simplex virus-infected wi-38 cells by phosphonoacetic Acid.

8 September 2023

142

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Co-existence of a guanidine-dependence and of a thiopyrimidine dependence in the same strain of poliovirus

8 September 2023

144

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.

8 September 2023

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

On the mechanism of the inhibitory action of 2-amino-4,6-dichloropyrimidine on poliovirus growth

8 September 2023

146

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Low virulence and immunogenicity in mice and in rabbits of variants ofHerpes simplex virus resistant to 5-iodo-2-deoxyuridine

8 September 2023

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral action of gliotoxin

8 September 2023

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rifampicin inhibition of vaccinia replication

8 September 2023

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral action of gliotoxin

8 September 2023

150

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rapid development of drug-resistant mutants of poliovirus.

8 September 2023

151

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Specific inhibition of viral ribonucleic acid replication by Gliotoxin.

8 September 2023

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Vaccinia virus directed RNA and protein synthesis in the presence of rifampicin

8 September 2023

154

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rifampicin: a specific inhibitor of vaccinia virus assembly

8 September 2023

155

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Assembly of vaccinia virus particles from polypeptides made in the presence of rifampicin

8 September 2023

156

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Assembly of virus particles during mixed infection with wild-type vaccinia and a rifampicin-resistant mutant

8 September 2023

157

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Polyadenylate Polymerase from Vaccinia Virions

8 September 2023

158

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A GUANIDINE-DEPENDENT VARIANT OF POLIOVIRUS. ISOLATION OF A VARIANT AND SOME OF ITS BIOLOGICAL PROPERTIES.

8 September 2023

160

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

ANTIVIRAL ACTIVITY OF AMANTADINE HYDROCHLORIDE IN TISSUE CULTURE AND IN OVO

8 September 2023

161

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication

8 September 2023

162

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

New 1,2-disubstituted benzimidazoles with high inhibiting effects on poliovirus replication

8 September 2023

164

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral potential of phosphonoacetic acid

8 September 2023

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Inhibition of herpes simplex virus replication by phosphonoacetic acid

8 September 2023

166

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Immunofluorescent Studies on the Inhibition of Influenza A and B Viruses in Mammalian Cell Cultures by Amines and Ammonium Compounds

8 September 2023

167

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

In vivo Selection of an Influenza A2 Strain resistant to Amantadine

8 September 2023

168

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral phenoxathiins and their analogs. Study of the structure-activity relationships for antiviral activity and the replacement ability in poliovirus type 3 dependent variants

8 September 2023

170

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

STIMULATION OF THE INCORPORATION OF CHOLINE IN POLIOVIRUS-INFECTED CELLS

8 September 2023

173

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Isatin-beta-thiosemicarbazone causes premature cessation of vaccinia virus-induced late post-replicative polypeptide synthesis

8 September 2023

174

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The reversion of guanidine inhibition of poliovirus synthesis

8 September 2023

175

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Biogenesis of vaccinia: effect of rifampicin on transcription

8 September 2023

176

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

INHIBITION OF MULTIPLICATION OF FOOT-AND-MOUTH DISEASE VIRUS BY GUANIDINE HYDROCHLORIDE.

8 September 2023

177

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

INCORPORATION OF 5-IODO-2'-DEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF VACCINIA VIRUS.

8 September 2023

181

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Cellular and antiviral effects of halogenated deoxyribonucleosides

8 September 2023

182

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Recent studies on the antiviral and biochemical properties of 5-halo-5'-amino-deoxyribonucleosides

8 September 2023

183

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The inhibitory effect of 6-azauracil riboside on the multiplication of vaccinia virus

8 September 2023

184

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Development of resistance to antiviral drugs.

8 September 2023

185

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Methisazone in prevention of variola minor among contacts.

8 September 2023

186

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral effect of guanidine

8 September 2023

187

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral Activity of Gliotoxin and Gliotoxin Acetate

8 September 2023

188

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

THE MULTIPLICATION OF HERPES SIMPLEX VIRUS. I. THE PROGRAMMING OF VIRAL DNA DUPLICATION IN HEP-2 CELLS.

8 September 2023

189

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral chemotherapy with isatin-beta-thiosemicarbazone and its derivatives

8 September 2023

191

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

8 September 2023

198

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

On the Mechanism of Inhibition of Influenza Virus Replication by Amantadine Hydrochloride

8 September 2023

199

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

BIOLOGIC INVESTIGATIONS OF A NUCLEIC ACID ANALOG-DEPENDENT HERPESVIRUS

8 September 2023

202

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A nucleic acid analogue dependent animal virus

8 September 2023

203

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Rifampicin inhibits the growth of some mammalian viruses.

8 September 2023

205

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

A new antirhinovirus compound, ICI 73602: structure, properties, and spectrum of activity

8 September 2023

206

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Mutation of polioviruses to resistance to neutralizing substances in normal bovine sera

8 September 2023

207

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Sensitivity and resistance of type 1 polioviruses to an inhibitor in certain horse sera

8 September 2023

208

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Virus-polysaccharide interactions. II. Enhancement of plague formation and the detection of variants of poliovirus with dextran sulfate

8 September 2023

209

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl.

8 September 2023

210

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES

8 September 2023

211

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity. Inhibition of poliovirus multiplication and cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole, and its 5-chloroderivative

8 September 2023

213

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Antiviral effect of guanidine and its derivatives. I. The inhibitory effect of guanidine on the multiplication of poliomyelitis virus in tissue culture.

8 September 2023

217

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

THE ANTIVIRAL EFFECT OF GUANIDINE AND ITS DERIVATIVES: III. THE DEVELOPMENT OF GUANIDINE RESISTANT AND GUANIDINE DEPENDENT POLIO VIRUS IN TISSUE CULTURE

8 September 2023

218

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Activity of 1-beta-D-arabinofuranosylcytosine hydrochloride against herpes simplex keratitis

8 September 2023

220

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Herpes keratitis in rabbits: pathogenesis and effect of antiviral nucleosides

8 September 2023

221

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Actions of the rifamycins

8 September 2023

222

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

The inhibition of vaccinia virus multiplication by isatin-beta-thiosemicarbazone

8 September 2023

223

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

Host-cell involvement in the expression of the guanidine-dependent phenotype of poliovirus

8 September 2023

225

1 reference

https://api.crossref.org/works/10.1016/0163-7258(80)90026-1

8 September 2023

Identifiers

1 reference

17 September 2017

1 reference